niceritrol has been researched along with Chronic Kidney Failure in 6 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Shoji, T | 1 |
| Nishizawa, Y | 1 |
| Kawasaki, K | 1 |
| Tabata, T | 1 |
| Matsushita, Y | 1 |
| Inoue, T | 1 |
| Morii, H | 1 |
| Shimoda, K | 1 |
| Akiba, T | 1 |
| Matsushima, T | 1 |
| Rai, T | 1 |
| Abe, K | 1 |
| Hoshino, M | 1 |
| Saika, Y | 1 |
| Kodama, N | 1 |
| Kimura, K | 1 |
| Fujii, R | 1 |
| Ohtani, H | 1 |
| Mune, M | 1 |
| Mimura, K | 2 |
| Maeda, T | 1 |
| Yukawa, S | 2 |
| Wakasugi, H | 1 |
| Futami, T | 1 |
| Muso, E | 1 |
| Ono, T | 1 |
| Sasayama, S | 1 |
| Inui, K | 1 |
1 review available for niceritrol and Chronic Kidney Failure
| Article | Year |
|---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
1 trial available for niceritrol and Chronic Kidney Failure
| Article | Year |
|---|---|
Effects of the nicotinic acid analogue niceritrol on lipoprotein Lp(a) and coagulation-fibrinolysis status in patients with chronic renal failure on hemodialysis.
Topics: Blood Coagulation; Female; Fibrinolysis; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Lipo | 1997 |
4 other studies available for niceritrol and Chronic Kidney Failure
| Article | Year |
|---|---|
[Niceritrol decreases serum phosphate levels in chronic hemodialysis patients].
Topics: Anticholesteremic Agents; Cholesterol, HDL; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; M | 1998 |
[Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol].
Topics: Arteriosclerosis; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoprotein(a); Niacin; Nic | 1999 |
Thrombocytopenia and anemia induced by niceritrol used for amelioration of hyperphosphatemia in a hemodialysis patient.
Topics: Anemia; Female; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Middle Aged; Niceritrol; Phos | 2000 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidn | 1991 |